Εμφανίζονται 1 - 1 Αποτελέσματα από 1 για την αναζήτηση '"лазерное омоложение"', χρόνος αναζήτησης: 0,38δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Συνεισφορές: The authors declare no funding, Авторы заявляют об отсутствии финансирования

    Πηγή: Obstetrics, Gynecology and Reproduction; Vol 19, No 5 (2025); 788-799 ; Акушерство, Гинекология и Репродукция; Vol 19, No 5 (2025); 788-799 ; 2500-3194 ; 2313-7347

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.gynecology.su/jour/article/view/2599/1400; Клинические рекомендации. Менопауза и климактерическое состояние у женщины. М.: Министерство здравоохранения Российской Федерации, 2024. 93 с. Режим доступа: https://drive.google.com/file/d/1S8V8Tg-SXj3Nms4uZvkau47LRHzuVhXn/view. [Дата обращения: 15.06.2025].; Vodegel E.V., Kastelein A.W., Jansen C.H.J.R. et al. The effects of oestrogen on vaginal wound healing: A systematic review and meta-analysis. Neurourol Urodyn. 2022;41(1):115–26. https://doi.org/10.1002/NAU.24819.; Abrams P., Cardozo L., Fall M. et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49. https://doi.org/10.1016/S0090-4295(02)02243-4.; ICS Standards 2022. Режим доступа: https://www.ics.org/members/shop/icsstandards2022. [Дата обращения: 15.06.2025].; Rossouw J.E., Anderson G.L., Prentice R.L. et al.; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. J Am Med Assoc. 2002;288(3):321–33. https://doi.org/10.1001/JAMA.288.3.321.; Sturdee D.W., Panay N.; International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509–22. https://doi.org/10.3109/13697137.2010.522875.; Chapple C.R., Siddiqui E. Mirabegron for the treatment of overactive bladder: a review of efficacy, safety and tolerability with a focus on male, elderly and antimuscarinic poor-responder populations, and patients with OAB in Asia. Expert Rev Clin Pharmacol. 2017;10(2):131–51. https://doi.org/10.1080/17512433.2017.1275570.; Nager C.W. Brubaker L., Litman H.J. et al.; Urinary Incontinence Treatment Network. A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med. 2012;366(21):1987–97. https://doi.org/10.1056/NEJMOA1113595.; Weber M.A., Kleijn M.H., Langendam M. et al. Local oestrogen for pelvic floor disorders: a systematic review. PLoS One. 2015;10(9):e0136265. https://doi.org/10.1371/JOURNAL.PONE.0136265.; Rahn D.D., Carberry C., Sanses T.V. et al.; Society of Gynecologic Surgeons Systematic Review Group. Vaginal estrogen for genitourinary syndrome of menopause. Obstet Gynecol. 2014;124(6):1147–56. https://doi.org/10.1097/AOG.0000000000000526.; Castelo-Branco C., Cancelo M.J., Villero J. et al. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas. 2005;52 Suppl 1:S46–52. https://doi.org/10.1016/j.maturitas.2005.06.014.; Клинические рекомендации – Недержание мочи – 2024-2025-2026 (07.08.2024). М.: Министерство здравоохранения Российской Федерации, 2024. 40 с. Режим доступа: http://disuria.ru/_ld/14/1449_kr24N39R32MZ.pdf. [Дата обращения: 15.06.2025].; Marschalek M.L., Bodner K., Kimberger O. et al. Does preoperative locally applied estrogen treatment facilitate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse? A randomised controlled double-masked, placebo-controlled, multicentre study. BJOG. 2021;128(13):2200–08. https://doi.org/10.1111/1471-0528.16894.; Chen Y.Y., Su T.H., Lau H.H. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials. Int Urogynecol J. 2021;32(1):17–25. https://doi.org/10.1007/S00192-020-04397-Z.; Su I.H., Chen Y-C., Hwang W.-T. et al. Risks and benefits of menopausal hormone therapy in postmenopausal Chinese women. Menopause. 2012;19(8):931–41. https://doi.org/10.1097/GME.0B013E31824362FF.; Kingsberg S.A., Wysocki S., Magnus L., Krychman M.L. Vulvar and vaginal atrophy in postmenopausal women: Findings from the REVIVE (REal women’s VIews of treatment options for menopausal vaginal changEs) survey. J Sex Med. 2013;10(7):1790–9. https://doi.org/10.1111/JSM.12190.; Coyne K.S., Sexton C.C., Irwin D.E. et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008;101(11):1388–95. https://doi.org/10.1111/J.1464-410X.2008.07601.X.; Koirala R., Gargari G., Arioli S. et al. Effect of oral consumption of capsules containing Lactobacillus paracasei LPC-S01 on the vaginal microbiota of healthy adult women: a randomized, placebo-controlled, double-blind crossover study. FEMS Microbiol Ecol. 2020;96(6):fiaa084. https://doi.org/10.1093/FEMSEC/FIAA084.; Athanasiou S., Pitsouni E., Grigoriadis T. et al. Mirabegron in female patients with overactive bladder syndrome: What’s new? A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;251:73–82. https://doi.org/10.1016/j.ejogrb.2020.05.018.; Mension E., Alonso I., Tortajada M. et al. Vaginal laser therapy for genitourinary syndrome of menopause – systematic review. Maturitas. 2022;156:37–59. https://doi.org/10.1016/j.maturitas.; https://www.gynecology.su/jour/article/view/2599